Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Colon cancer rates are rising among young people – could changes to children’s gut bacteria explain why?
Justin Stebbing, Anglia Ruskin University Alarming trends show that colon or bowel cancer is increasing…
Cancer Council NSW announces over $5.8million in funding for the cancer research breakthroughs of tomorrow
Cancer Council NSW is thrilled to announce the allocation of over $5.8 million in funding…
Bacteria-enhanced graphene oxide nanoparticles for triple-action tumour eradication
Modern cancer treatments have evolved beyond traditional chemotherapy to include targeted approaches such as immunotherapy,…
AACR 2023: SWOG S1512 trial sees high response rate to pembrolizumab in patients with unresectable desmoplastic melanoma
- New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy
- Do vitamin D levels affect the body’s response to anti-cancer immunotherapy?
- Moderna’s experimental cancer vaccine treats but doesn’t prevent melanoma – a biochemist explains how it works
Ovarian cancer is not a silent killer
Barbara Goff, University of Washington Ovarian cancer is the most deadly of gynecologic tumours. Fewer than 40% of those diagnosed…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.